Archer Daniels Midland to end venture with Metabolix
Archer Daniels Midland Co. said Thursday it is ending a biodegradable plastics joint venture with Metabolix Inc. because of the venture's cost, and uncertainty about its returns.
Abbott has completed the separation of its research-based pharmaceuticals business into AbbVie, a new independent biopharmaceutical company that starts trading today on the New York Stock Exchange.